(Date:12/5/2008)...provides physicians and their office managers easy... Columbus, OH (PRWEB) December 5, ...nched Phase I of PHYZOOM, a suite of web-based phy..., PHYZOOM offers numerous practice marketing and c... and practice profiles, easy to use blogging tools...
(Date:12/4/2008)...re-USNewswire/ -- Health Care Without Harm and th...l partnership to substitute mercury-based medical ...atives. , , The announcement came during th...tives to Mercury in Health Care, an event sponsore...cs Link. , , "This initiative aims to repla...
(Date:12/4/2008)...f drive to eliminate lymphatic filariasis (LF) wit... grant to The Carter Center , , LONDON and ...a meeting today with former U.S. President and fou...s global health thought leaders from around the wo...that it has made a $250,000 donation to The Carter...
(Date:12/4/2008)...Aurora Health Care is ramping up its,efforts to p...Care Management,Clinical Leadership Team members ...ers about the benefits of Vitamin D. The decision ...tamin D levels may improve outcomes for,patients ...onditions and,seasonal depression. , "We a...
Breaking Medicine News(10 mins):Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 2Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 3Health News:Health Care Without Harm, WHO Announce Partnership for Global Reduction of Mercury-Based Medical Devices 2Health News:GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program 2Health News:GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program 3Health News:GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program 4Health News:Aurora Health Care Urges All Wisconsin Residents to Take Vitamin D 2(Date:12/3/2008)...Dec. 3 Wyeth Pharmaceuti...ed today that it has submitted a,marketing author...s Agency,(EMEA) for approval to market its invest...e (PCV13) for infants and young children. Wyeth i...umococcal disease (PD) caused by the 13,serotypes...
(Date:12/3/2008)...PRNewswire-FirstCall/ -- Vical Incorporated,(Nasd... letter of intent with EIP,Eczacibasi Ilac Pazarl...any,s,Allovectin-7(R) immunotherapeutic product c...rthern Cyprus. EIP has agreed to obtain the necess... pay Vical upfront and milestone payments,plus a ...
(Date:12/2/2008)...2 IBT Laboratories, a leading cli...ry specializing in immunology and allergy assays, ...ate the response of patients whose immune systems...ncy disorder, chemotherapy drugs, or because they ...ection of a transplant. The company launched the t...
(Date:12/1/2008)...Newswire-USNewswire/ -- New research has found tha...ted tomography (CT) scanner in an emergency room c...tims who receive a potentially life-saving treatme... Medical Center (NSMC)-Salem Hospital in Salem, Ma... of the Radiological Society of North America (RSN...
Breaking Medicine Technology:Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Super Jake Foundation Hosts 3rd Annual Heroes Bash on Nov 3 to Benefit Pediatric Cancer Research 2664 1Super Jake Foundation Hosts 3rd Annual Heroes Bash on Nov 3 to Benefit Pediatric Cancer Research 2664 2Super Jake Foundation Hosts 3rd Annual Heroes Bash on Nov 3 to Benefit Pediatric Cancer Research 2664 3Cancer researchers seek safe reduction of radiotherapy 2663 1Cancer researchers seek safe reduction of radiotherapy 2663 2FDA approves knee injury device for humans 2660 1FDA approves knee injury device for humans 2660 2Drug Combo Helps Fight Marfan Syndrome 2658 1Drug Combo Helps Fight Marfan Syndrome 2658 2...published today shows reduction of 70,percent in s...ST HANOVER, N.J., May 02, 2007 /PRNewswire/ -- A o...d) Injection significantly,reduced the incidence o...ree years in women with postmenopausal osteoporosi...Journal of Medicine,marks the first time that an ...
... of Pain on Sleep Interference, INDIANAPOLIS, May ...led analysis of three studies suggest that in pati... diabetic peripheral neuropathy,who are treated w...h average daily pain and night pain severity were ...ce than in those patients,taking sugar pill. Resul...
Other Medicine Technology:Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: